Bruker (BRKR) Tops Q4 EPS by 1c, Offers Guidance

Bruker (NASDAQ: BRKR) reported Q4 EPS of $0.74, $0.01 better than the analyst estimate of $0.73. Revenue for the quarter came in at $708.4 million versus the consensus estimate of $680.1 million.

GUIDANCE:

Bruker sees FY2023 EPS of $2.52-$2.57, versus the consensus of $2.57. Bruker sees FY2023 revenue of $2.81-2.86 billion, versus the consensus of $2.61 billion.

For earnings history and earnings-related data on Bruker (BRKR) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Array Technologies (ARRY) PT Lowered to $10 at Jefferies, 'Playing Offense Amid Preferred Anxiety'
• Yara to buy Gulf Coast Ammonia plant in Texas for $1.3B